{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:13:28Z","timestamp":1771485208586,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neuropharm.2023.109787","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:23:34Z","timestamp":1698780214000},"page":"109787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Methylone produces antidepressant-relevant actions and prosocial effects"],"prefix":"10.1016","volume":"242","author":[{"given":"Zhenlong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau-Shoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzer-Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-9814","authenticated-orcid":false,"given":"Cheng-Yuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lih-Chyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ci","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-8495","authenticated-orcid":false,"given":"Dylan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109787_bib1","article-title":"A case series providing clinical evidence that methylone produces rapid and robust improvements in major depressive disorder","volume":"14","author":"Averill","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109787_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","article-title":"Psychoactive \"bath salts\": not so soothing","volume":"698","author":"Baumann","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib4","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41386-019-0402-z","article-title":"Effects of MDMA on attention to positive social cues and pleasantness of affective touch","volume":"44","author":"Bershad","year":"2019","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108068","article-title":"Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions","volume":"170","author":"Chou","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108361","article-title":"Topiramate inhibits offensive aggression through targeting ventrolateral periaqueductal gray","volume":"181","author":"Chou","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2014.02.016","article-title":"Brain-derived neurotrophic factor in the amygdala mediates susceptibility to fear conditioning","volume":"255","author":"Chou","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.06.033","article-title":"(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","volume":"139","author":"Chou","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","article-title":"Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines","volume":"381","author":"Cozzi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2019.03.017","article-title":"Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)","volume":"151","author":"Curry","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109077","article-title":"The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus","volume":"212","author":"D'Oliveira da Silva","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib12","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","article-title":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study","volume":"235","author":"Danforth","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pbb.2016.05.003","article-title":"Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone","volume":"146\u2013147","author":"Daniel","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109787_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","article-title":"Long-term cognitive and neurochemical effects of \"bath salt\" designer drugs methylone and mephedrone","volume":"103","author":"den Hollander","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109787_bib15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10803-007-0486-x","article-title":"Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET)","volume":"38","author":"Dziobek","year":"2008","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2023.109787_bib16","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnana.2019.00048","article-title":"The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine and acetylcholine from the brainstem reticular formation","volume":"13","author":"Ferrucci","year":"2019","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2023.109787_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2019.03.004","article-title":"Periaqueductal gray sheds light on dark areas of psychopathology","volume":"42","author":"George","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109787_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/npp.2017.199","article-title":"Periaqueductal gray glutamatergic transmission governs chronic stress-induced depression","volume":"43","author":"Ho","year":"2018","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib20","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-016-4310-1","article-title":"Antidepressant activity of nociceptin\/orphanin FQ receptor antagonists in the mouse learned helplessness","volume":"233","author":"Holanda","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2017.10.022","article-title":"Effect fingerprinting of new psychoactive substances (NPS): what can we learn from in vitro data?","volume":"182","author":"Hondebrink","year":"2018","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109787_bib22","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/scan\/nst161","article-title":"MDMA enhances emotional empathy and prosocial behavior","volume":"9","author":"Hysek","year":"2014","journal-title":"Soc. Cognit. Affect Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109787_bib23","series-title":"Emeryville, CA: Neurobiological Technologies Inc","article-title":"Novel N-substituted 2-amino-3\u2019,4\u2019-methylene-dioxypropiophenones","author":"Jacob","year":"1996"},{"key":"10.1016\/j.neuropharm.2023.109787_bib24","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.cub.2022.08.062","article-title":"A thalamo-preoptic pathway promotes social grooming in rodents","volume":"32","author":"Keller","year":"2022","journal-title":"Curr. Biol. : CB"},{"key":"10.1016\/j.neuropharm.2023.109787_bib25","series-title":"Clinical Evidence for the Use of Methylone in the Treatment of PTSD: A Case Series with Long-Term Follow- up","first-page":"2209","author":"Kelmendi","year":"2022"},{"key":"10.1016\/j.neuropharm.2023.109787_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr. Topics Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109787_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0269881117699617","article-title":"Multifaceted empathy of healthy volunteers after single doses of MDMA: a pooled sample of placebo-controlled studies","volume":"31","author":"Kuypers","year":"2017","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.neuropharm.2023.109787_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pnpbp.2013.04.007","article-title":"An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as \"bath salts\"","volume":"45","author":"L\u00f3pez-Arnau","year":"2013","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109787_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/ejn.13085","article-title":"Depression-like behaviour in mice is associated with disrupted circadian rhythms in nucleus accumbens and periaqueductal grey","volume":"43","author":"Landgraf","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109787_bib30","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1007\/s12035-023-03439-z","article-title":"Impaired ventrolateral periaqueductal gray-ventral tegmental area pathway contributes to chronic pain-induced depression-like behavior in mice","volume":"60","author":"Lee","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ijnp\/pyad027","article-title":"BTRX-246040 acts through the ventrolateral periaqueductal gray to exert antidepressant-relevant actions in mice","volume":"26","author":"Li","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2019.12.004","article-title":"Decreased glutamatergic synaptic strength in the periaqueductal gray contributes to maintenance of visceral pain in male rats with experimental pancreatitis","volume":"428","author":"Liu","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109787_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2019.05.014","article-title":"Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives)","volume":"855","author":"Luethi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/FBP.0b013e32834d0f05","article-title":"Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression","volume":"22","author":"Majumder","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109787_bib35","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2023.109787_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109787_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/npr2.12124","article-title":"Differential sensitivity to detect prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice","volume":"40","author":"Mukai","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2023.109787_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190297","article-title":"Periaqueductal efferents to dopamine and GABA neurons of the VTA","volume":"13","author":"Ntamati","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109787_bib39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00213-022-06086-9","article-title":"MDMA and memory, addiction, and depression: dose-effect analysis","volume":"239","author":"Pantoni","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.neuron.2022.12.027","article-title":"Dorsomedial prefrontal hypoexcitability underlies lost empathy in frontotemporal dementia","volume":"111","author":"Phillips","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109787_bib41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/biology10080788","article-title":"A comparison of acute pharmacological effects of methylone and MDMA administration in humans and oral fluid concentrations as biomarkers of exposure","volume":"10","author":"Poyatos","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314636","article-title":"Methylone and MDMA pharmacokinetics following controlled administration in humans","volume":"23","author":"Poyatos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109787_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fpsyt.2019.00138","article-title":"A review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted psychotherapy","volume":"10","author":"Sessa","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109787_bib44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fpsyt.2017.00232","article-title":"Pharmacokinetic, ambulatory, and hyperthermic effects of 3,4-methylenedioxy-N-methylcathinone (methylone) in rats","volume":"8","author":"\u0160tefkov\u00e1","year":"2017","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109787_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46128-5","article-title":"Rescue-like behaviour in mice is mediated by their interest in the restraint tool","volume":"9","author":"Ueno","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109787_bib46","first-page":"E4726","article-title":"Depression-like behavior in rat: involvement of galanin receptor subtype 1 in the ventral periaqueductal gray","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109787_bib47","article-title":"Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity","volume":"13","author":"Warner-Schmidt","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109787_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107667","article-title":"Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission","volume":"157","author":"Ye","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109787_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108984","article-title":"Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions","volume":"208","author":"Ye","year":"2022","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:27:47Z","timestamp":1758439667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823003775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"alternative-id":["S0028390823003775"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109787","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylone produces antidepressant-relevant actions and prosocial effects","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109787"}}